Medical Research: FDA greenlit the first human trial of kratom’s mitragynine for opioid use disorder, signaling a new push to study contentious natural compounds in controlled settings. Public Health & Youth Risk: A new study links cannabis + tobacco co-use in teens/young adults to lower cognitive scores, adding fuel to early-intervention arguments. Regulatory & Tax Pressure: GOP lawmakers warned that marijuana rescheduling could change federal tax treatment, but 280E limits may still trap operators. State Enforcement: Arkansas agents seized 25+ pounds of illegal THC products and arrested two for operating outside hemp/medical rules. International Crackdowns: India’s EAGLE Force says it dismantled a hydroponic cannabis syndicate spanning Thailand and India, with carriers, flights, and money trails; separate arrests targeted ganja transport networks. Market Access: Alabama’s first medical cannabis purchase and dispensary openings continue, while Kentucky dispensaries promote patient specials tied to concerts. Business Reality: A Fingerboard Farm hemp operator says farmers are surviving via multiple revenue streams as costs rise. Policy Culture: A cannabis industry commentary argues companies build compliance binders, not compliance culture—warning it could get more expensive.